Header Logo

Connection

David Bellini to Thymidine Kinase

Back to Details
This is a "connection" page, showing publications David Bellini has written about Thymidine Kinase.
David Bellini
Connection Strength
0.048
Thymidine Kinase
  1. Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy. PLoS One. 2022; 17(3):e0264822.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.